Blockchain, Food Loss, Food Waste, Food Tech, Supply Chain, Big Data, Ag Tech, Digitization, AI, Shelf Life Prediction, Quality Assessment, Fresh Produce, Dynamic Routing, UN SDG 12.3, Spectroscopy, Mobile App, and NIR Spectroscopy
Fiber Unlimited provides products, services, and full network solutions for in-door Plastic Optical Fiber (POF) networks.
Simple, cost effective thermal energy buffering for the built environment, with energy management software to optimise for sustainability and costs
Pleco Therapeutics is focused on developing innovative therapies for cancer, particularly orphan treatments for diseases with limited options. The company is currently engaged in pre-clinical development of its PlecoidTM medications, targeting Acute Myeloid Leukaemia and Small-Cell Lung Cancer, both of which are associated with poor prognoses. Pleco Therapeutics aims to enhance the effectiveness of existing chemotherapy regimens and improve patient outcomes by altering protein expression within the cancer microenvironment and alleviating the burden of toxic metals in cancer cells. Through these efforts, the company seeks to extend patient lifespans and improve their quality of life.
We offer a plug-and-play integrated and reconfigurable light-based quantum processor that accelerates the way to a quantum future.
Quantum computing will revolutionize the way of processing information as we know it. Integrated photonics is a key enabling technology for light-based quantum computers as it allows us to realize reconfigurable quantum processors that process single photons in a stable, accurate and fast way. At QuiX, we offer both integrated photonic processors and bespoke integrated devices for quantum photonics, based on the proprietary TriPleX platform.
Aiosyn uses artificial intelligence to develop algorithms to augment pathologist with clinical decision-making. The company develops a clinical diagnostics platform with multiple AI algorithms and connect with standard pathology workflows. Aiosyn's platform will also accelerate biopharma and diagnostics companies with developing AI-based biomarker development.
Prolira BV is a technology-driven company based in Utrecht, the Netherlands, specializing in the development of medical devices for the early detection of delirium, a condition characterized by acute brain failure. Founded in 2015 as a spin-off from the University Medical Center Utrecht, Prolira's flagship product, DeltaScan, utilizes electroencephalography (EEG) to analyze brain activity. The DeltaScan system consists of a single-use electrode patch, known as the DeltaScan Patch, and a monitoring module, the DeltaScan Monitor, which processes the EEG data. The company's management team collaborates with technical, market introduction, and clinical evaluation teams, supported by an advisory board and a clinical evaluation board comprised of leading academic medical centers in Europe.
River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing. Currently pharmaceutical companies spend a billion dollar figure on the development of a new drug entity, with a 90% chance of it failing to reach the market. The most common reason for failure during this developmental stage is drug induced cardiac toxicity. To solve this issue we develop 3D cardiac tissues, resembling the working human heart, for advanced drug discovery and toxicity screening using a multidisciplinary human stem cell-based approach.
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.
Fring operates a hiring platform designed to streamline the recruitment of freelancers for businesses seeking flexible talent. The platform connects companies with a diverse range of available freelancers, including skilled designers, developers, marketers, and media experts. By providing real-time access to this talent pool, Fring enables organizations to build adaptable teams and efficiently complete project tasks. Additionally, the platform allows freelancers to discover engaging projects, fostering a social connection within the freelance community. Through its innovative approach, Fring aims to redefine how businesses and freelancers collaborate, making the recruitment process more straightforward and effective.
Xenikos aims to develop a new medicine, based on the action of antibodies that enables patients suffering serious immune diseases, or rejection after transplantation, to reset their immune system quickly and efficiently. Xenikos strives to develop new, innovative immunotherapy medicines to help restore patients’ health and save lives.
ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. They exploit the latest methods in the rapidly evolving field of machine learning, combining these with very large well curated digital image databases and a thorough understanding of the physics of mammogram image formation and the practicalities of the clinical deployment of mammographic image analysis.
Blockchain, Food Loss, Food Waste, Food Tech, Supply Chain, Big Data, Ag Tech, Digitization, AI, Shelf Life Prediction, Quality Assessment, Fresh Produce, Dynamic Routing, UN SDG 12.3, Spectroscopy, Mobile App, and NIR Spectroscopy
Axign is a fabless chip supplier serving the worldwide audio markets in consumer and professional audio. Its first product is a breakthrough audio controller chip, that combines benchmark performance with a low bill of materials for audio system manufacturers. The chip is specially suited for active speaker systems in streaming audio devices.
InteRNA Technologies B.V. is a biotechnology company based in Nijmegen, the Netherlands, with a research and development center in Utrecht. Founded in 2006, the company focuses on developing microRNA (miRNA)-based therapeutics aimed at treating cancer. These drugs target previously undruggable pathways, enhancing the effectiveness of existing therapies and addressing drug resistance. InteRNA employs advanced techniques such as massively parallel sequencing and proprietary bioinformatics to analyze and validate miRNA sequences. Recently, the company secured additional equity financing to further advance its lead program for melanoma treatment, reflecting its commitment to innovation in oncology.
Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.
The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, a top performing early stage VC firm from U.S.
Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof.
Pepscope BV, a biotechnology company, develops protein kinase activity profiling technologies. The company offers QuantaKinome, a solution to the pharmaceutical industry and academic researchers to improve the discovery and development of novel kinase inhibitors and other therapeutic compounds to find new applications of existing compounds and in due course to select optimal therapies for individual patients. Pepscope BV was founded in 2012 and is based in Nijmegen, the Netherlands.
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.
GATT Technologies BV develops synthetic surgical hemostat and sealant products that control severe bleeding. The company provides products, such as GATT-Patch, a hemostatic sealing patch for general surgery; GATT-Tape, a tape for preventing intestinal anastomotic leakage; GATT-Spray, an adhesive elastic sealant for general surgery; and GATT-Powder, a hemostatic sealing powder. GATT Technologies BV was founded in 2011 and is based in Nijmegen, the Netherlands.
Make every word count The Textmetrics solutions enable organizations to create target group specific and corporate wide consistent content by using augmented assisted writing based on scientifically proven algorithms.. Textmetrics is your content quality platform.
Plasmacure specializes in the development of a technology to treat diabetic food wounds. Plasmacure is based in Eindhoven, the Netherlands.
MIMETAS B.V. develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The company's product portfolio includes OrganoPlate 2-lane, OrganoPlate 3-lane, and perfusion rocker. It offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded in 2013 and is based in Leiden, the Netherlands.
SuperBuddy operates as a delivery service for the daily shopping. SuperBuddy is based in the Netherlands.
Sound Energy BV is established to develop and commercialise new technologies to reduce fossile energy consumption. Their main focus is SoundEnergy’s breaktrough innovation in Thermo Acoustic Technology for Zero CO2 climate control of buildings. They are a modern company in sustainability, integrating environmental concern, scientific knowledge and business mentality. The environment will benefit most from technologies that are good cause as well as good investment.
Mellon Medical provides suturing tools for surgeons to improve medical procedures. The company's goal is to help medical specialists improve patient outcomes by providing them with the best possible suturing tools. It commercializes surgical instruments to allow single-handed stitching, enabling efficient and effective suturing of tubular and layered structures.
Mellon Medical was established in 2013 and is headquartered in Nijmegen, Gelderland.
Make every word count The Textmetrics solutions enable organizations to create target group specific and corporate wide consistent content by using augmented assisted writing based on scientifically proven algorithms.. Textmetrics is your content quality platform.
Experience the ease of use of this Dutch design. With ThermoSmart, you won’t get frustrated setting up and operating your thermostat.
Xenikos aims to develop a new medicine, based on the action of antibodies that enables patients suffering serious immune diseases, or rejection after transplantation, to reset their immune system quickly and efficiently. Xenikos strives to develop new, innovative immunotherapy medicines to help restore patients’ health and save lives.